hIL4-Tg(NMG)

Nomenclature

NOD.Cg-PrkdcscidIl2rgem1Tg(hIL4)Smoc

Cat. NO.

NM-KI-215004

Strain State

Embryo cryopreservation

Export PDF

Gene Summary

Gene Symbol
Il4

Model Description

These transgenic mice carry humanized IL4.

Validation Data

image.png

Fig.1 Detection of IL4 expression in adrenal, intestine and lung of 8-week-old male mice by RT-PCR. 

Wild type: Only one band at 123 bp with primers F/R(mGapdh).

Homozygous: One band at 223 bp with primers F1/R1(hIL4) and one band at 123 bp with primers F/R(mGapdh).

Abbr. M, DNA marker; HO, homozygous; WT, wild type.

image.png

Fig 2. Detection of IL4 expression in adrenal, intestine and lung of 8-week-old male mice by qPCR (n=2). 

Abbr. M, DNA marker; HO, homozygous; WT, wild type.

image.png

Fig 3. Detection of human IL4 expression in serum of 8-week-old male mice by ELISA (n=2). 

Abbr.  HO, homozygous; WT, wild type; N.D. not detected.

image.png

Fig 4. Body weight growth curve of huPBMC-NMG-hIL4 mice. 

image.png

Fig 5. Survival rate of huPBMC-NMG-hIL4 mice. 

image.png

Fig 6. GvHD scores of huPBMC-NMG-hIL4 mice. 

image.png

Fig 7. Percentage of hCD45-positive cells in peripheral blood of huPBMC-NMG-hIL4 mice. 

image.png

Fig 8. Flow analysis of peripheral blood lymphocyte subpopulations in the huPBMC-NMG-hIL4 model. Human PBMCs (1E7) were injected intravenously into hIL4-Tg(NMG) mice (female, 6-8 weeks old, n=10). Blood from mice at different time points after implantation of human PBMCs was taken for flow cytometric analysis.


You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Workshop:Progress and Advances in Preclinical immuno-Oncology Research

SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.

Learn more